Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

213 Episodio

  1. Fluvoxamine for Treating COVID-19

    Pubblicato: 7/1/2022
  2. Prescribing Antidepressants During Breastfeeding

    Pubblicato: 2/1/2022
  3. Treatment Strategies for Acute and Chronic Insomnia

    Pubblicato: 28/12/2021
  4. Drug Use in Breastfeeding and Adverse Effects

    Pubblicato: 23/12/2021
  5. Marine Omega-3 Fatty Acid Supplementation for BPD

    Pubblicato: 18/12/2021
  6. Breastfeeding and Estimating Infant Drug Exposure

    Pubblicato: 13/12/2021
  7. A Method for Tapering Antipsychotics

    Pubblicato: 8/12/2021
  8. Management of Psychiatric Comorbidities With Alcohol Use Disorder

    Pubblicato: 3/12/2021
  9. Tips for Treating Perimenopausal Depression

    Pubblicato: 28/11/2021
  10. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

    Pubblicato: 23/11/2021
  11. Subclinical Hypothyroidism in Depressed Adolescents

    Pubblicato: 18/11/2021
  12. Principles for Managing Alcohol Use Disorder

    Pubblicato: 13/11/2021
  13. ECT for Depressed Patients With Borderline Personality Disorder

    Pubblicato: 8/11/2021
  14. Assessing and Treating Alcohol Withdrawal

    Pubblicato: 3/11/2021
  15. Lab Tests in Psychopharmacology

    Pubblicato: 29/10/2021
  16. Technology-Facilitated Adherence Enhancement and Family Involvement

    Pubblicato: 24/10/2021
  17. Drug-Induced Hyperthermic Syndromes in Psychiatry

    Pubblicato: 19/10/2021
  18. How to Improve Adherence: Targeting Reasons for Nonadherence

    Pubblicato: 14/10/2021
  19. Esketamine: Postmarketing Safety Concerns

    Pubblicato: 9/10/2021
  20. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Pubblicato: 4/10/2021

10 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site